Healthcare & Life Sciences News and Articles

Google News – Oncology External News

HRV Pharma deploys ₹150 crore to expand peptide, oncology API portfolio - pharma.economictimes.indiatimes.com

news.google.com · 08 Sep 2026

Google News – Oncology External News

HRV Pharma deploys ₹150 crore to expand peptide, oncology API portfolio - pharma.economictimes.indiatimes.com

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval and Launch Strategy for ZANVASTRO in Alexander Disease - Slideshow (NASDAQ:IONS) 2026-09-07 - Seeking Alpha

news.google.com · 08 Sep 2026

Google News – Biopharma External News

iX BIOPHARMA: Why a Rare US Emergency Declaration Matters for Its Star Product - NextInsight

news.google.com · 08 Sep 2026

Google News – Clinical Trials External News

AI-Designed Drug Shows Signs of Lowering Biological Age in Early Clinical Study - theaiinsider.tech

news.google.com · 08 Sep 2026

Google News – Clinical Trials External News

Osteoarthritis Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

EU pharma industry pushes for expansion of barcodes on medicines - Pharmaceutical Technology

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Aptar Pharma to support Aceso’s inhaled cystic fibrosis candidate’s advance - Pharmaceutical Technology

news.google.com · 08 Sep 2026

Google News – Biopharma External News

Clover Biopharma Says Combo RSV Shots Cut Respiratory Infections 62% in Phase 2 Trial - finance.biggo.com

news.google.com · 08 Sep 2026

Google News – Clinical Trials External News

The Mitochondrial Switch That Makes Drugs Different From Food - The Clinical Trial Vanguard

news.google.com · 08 Sep 2026

Google News – FDA (biotech/pharma) External News

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops - The Times of India

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

REGN 1-WEEK DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. Investors Alerted to September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - PR Newswire

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals - GlobeNewswire

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm - lincolnjournal.com

news.google.com · 08 Sep 2026

Google News – Oncology External News

HRV Pharma invests ₹150 crore to boost peptide, oncology API capacity - The Times of India

news.google.com · 08 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

HRV Pharma deploys ₹150 crore to expand peptide, oncology API portfolio - pharma.economictimes.indiatimes.com

HRV Pharma deploys ₹150 crore to expand peptide, oncology API portfolio - pharma.economictimes.indiatimes.com

Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval and Launch Strategy for ZANVASTRO in Alexander Disease - Slideshow (NASDAQ:IONS) 2026-09-07 - Seeking Alpha

iX BIOPHARMA: Why a Rare US Emergency Declaration Matters for Its Star Product - NextInsight

AI-Designed Drug Shows Signs of Lowering Biological Age in Early Clinical Study - theaiinsider.tech

Osteoarthritis Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com

EU pharma industry pushes for expansion of barcodes on medicines - Pharmaceutical Technology

Aptar Pharma to support Aceso’s inhaled cystic fibrosis candidate’s advance - Pharmaceutical Technology

Clover Biopharma Says Combo RSV Shots Cut Respiratory Infections 62% in Phase 2 Trial - finance.biggo.com

The Mitochondrial Switch That Makes Drugs Different From Food - The Clinical Trial Vanguard

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops - The Times of India

REGN 1-WEEK DEADLINE ALERT: Regeneron Pharmaceuticals, Inc. Investors Alerted to September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - PR Newswire

Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals - GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm - lincolnjournal.com

HRV Pharma invests ₹150 crore to boost peptide, oncology API capacity - The Times of India